Voloridge Investment Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-236,543
| Closed | -$4.49M | – | 1488 |
|
|
2023
Q2 | $4.49M | Sell |
236,543
-150,774
| -39% | -$2.86M | 0.02% | 709 |
|
|
2023
Q1 | $6.01M | Buy |
387,317
+181,483
| +88% | +$2.81M | 0.03% | 621 |
|
|
2022
Q4 | $3.65M | Buy |
+205,834
| New | +$3.65M | 0.02% | 766 |
|
|
2022
Q1 | – | Sell |
-180,395
| Closed | -$1.54M | – | 1534 |
|
|
2021
Q4 | $1.54M | Sell |
180,395
-185,398
| -51% | -$1.58M | 0.01% | 1150 |
|
|
2021
Q3 | $3.18M | Sell |
365,793
-2,936
| -0.8% | -$25.5K | 0.02% | 866 |
|
|
2021
Q2 | $3.9M | Sell |
368,729
-61,286
| -14% | -$648K | 0.03% | 732 |
|
|
2021
Q1 | $6.9M | Buy |
+430,015
| New | +$6.9M | 0.05% | 431 |
|